Enhance MD vs PeterMD: Which GLP-1 Provider Is Better?
A side-by-side comparison of Enhance MD and PeterMD covering pricing, scores, medication types, insurance, and more to help you decide.
Enhance MD
#8 of 31Affordable telehealth provider offering both compounded and brand-name GLP-1 medications with combination therapy options.
Visit Enhance MDPeterMD
#28 of 31One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.
Visit PeterMD| Feature | Enhance MD | PeterMD |
|---|---|---|
| Our Score | 8.3/10 | 7.5/10 |
| Starting Price | $115/mo | $105/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-conscious users interested in combination therapies | Budget-conscious users looking for the lowest monthly GLP-1 cost |
| Ranking | #8 | #28 |
Pros & Cons Compared
Enhance MD
Pros
- +$115/mo starting price with access to both brand-name and compounded — rare at this price point
- +Offers combination therapies (GLP-1 + B12, GLP-1 + NAD+) for patients wanting enhanced protocols
- +Quick asynchronous consultations — most patients approved within 24 hours without video calls
- +Flexible dosing: can start at lower doses than standard protocols for sensitive patients
Cons
- −Lighter clinical support than higher-priced platforms — check-ins are patient-initiated, not scheduled
- −No insurance billing and limited customer support hours (business days only, no weekends)
PeterMD
Pros
- +Very affordable
- +Simple process
- +Low monthly cost
- +Easy onboarding
Cons
- −Compounded only
- −Less comprehensive support
Our Verdict
Enhance MD edges out PeterMD with a score of 8.3/10 vs 7.5/10. If budget is your priority, PeterMD starts at $105/mo compared to Enhance MD's $115/mo. Enhance MD offers both brand-name and compounded medications, giving you more flexibility. Choose Enhance MD if you want: budget-conscious users interested in combination therapies. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.